keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZ 12799734 is an orally active, selective and potent dual inhibitor of TGFBR1 and ALK5 with inhibitory effects on BMP and TGFβ for the study of tumours.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 26,000 | |||
10 mg | 在庫あり | ¥ 42,500 | |||
25 mg | 在庫あり | ¥ 91,500 | |||
50 mg | 在庫あり | ¥ 152,000 | |||
100 mg | 在庫あり | ¥ 212,500 | |||
500 mg | 在庫あり | ¥ 424,500 |
説明 | AZ 12799734 is an orally active, selective and potent dual inhibitor of TGFBR1 and ALK5 with inhibitory effects on BMP and TGFβ for the study of tumours. |
ターゲット&IC50 | ACVR1:6.2 μM (Kd), ALK5:0.74 μM (Kd), BMPR1A:40 μM (Kd), ALK1:7.1 μM (Kd), ALK4:1 μM (Kd), TGFβRI:47 nM, ALK6:0.017 μM (Kd) |
In vitro |
Inhibiting ligand-activated SMAD3/4 transcription, AZ12799734[2]. AZ12799734 (10 nM; 24 h) inhibits phosphorylation of both SMAD1 and SMAD2[2]. AZ12799734 (500 nM; 36 h) inhibits TGFβ-induced migration in HaCaT epithelial cells[2]. |
In vivo |
Inducing histopathologic heart valve lesions in rats, AZ12799734 is administered orally at doses ranging from 0 to 400 mg/kg/day for 3-7 days[1]. At a single oral dose of 50 mg/kg, AZ12799734 shows total and free pharmacokinetic (PK) levels in nude mice over time, exceeding the in vitro IC50 of 0.01885 μM[2]. |
別名 | AZ12799734 |
分子量 | 370.43 |
分子式 | C18H18N4O3S |
CAS No. | 1117684-36-2 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (215.97 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZ 12799734 1117684-36-2 Angiogenesis Tyrosine Kinase/Adaptors ALK AZ12799734 AZ-12799734 Inhibitor inhibitor inhibit